Global Pharmaceuticals & Biotech Big Green Snowflakes

Biosergen

Market Cap: SEK 107.5m

A biotech company, develops antifungal products.

Pharvaris

Market Cap: US$1.7b

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Modalis Therapeutics

Market Cap: JP¥6.6b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

PanGen Biotech

Market Cap: ₩83.7b

Operates as a biologics company in South Korea.

Shandong Lukang PharmaceuticalLtd

Market Cap: CN¥8.8b

Operates as a pharmaceutical company in China.

NanoSphere Health Sciences

Market Cap: CA$256.9k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

Genetic Signatures

Market Cap: AU$59.1m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Zhuhai Rundu Pharmaceutical

Market Cap: CN¥4.7b

Develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide.

Yung Zip Chemical Ind

Market Cap: NT$906.8m

Yung Zip Chemical Ind. Co., Ltd., manufacturing, trading and sale of pharmaceuticals, pharmaceuticals, agricultural and industrial drugs, APIs, specialty chemicals and other related products internationally.

Uni-Bio Science Group

Market Cap: HK$949.4m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.

Nanjing Leads Biolabs

Market Cap: HK$12.6b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

InnoCare Pharma

Market Cap: HK$33.4b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Savior Lifetec

Market Cap: NT$6.0b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

Medico Remedies

Market Cap: ₹3.2b

Develops, manufactures, and sells pharmaceutical and nutraceutical products in India.

DBV Technologies

Market Cap: €206.8m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Soleno Therapeutics

Market Cap: US$3.7b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

LENZ Therapeutics

Market Cap: US$1.1b

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Valneva

Market Cap: €652.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Vicore Pharma Holding

Market Cap: SEK 2.7b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Annexin Pharmaceuticals

Market Cap: SEK 197.7m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Oxford BioDynamics

Market Cap: UK£9.0m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

Applied Therapeutics

Market Cap: US$63.4m

A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.

Nurix Therapeutics

Market Cap: US$703.3m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Madrigal Pharmaceuticals

Market Cap: US$10.0b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Xspray Pharma

Market Cap: SEK 1.7b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Planet 13 Holdings

Market Cap: CA$122.0m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

ImmunoPrecise Antibodies

Market Cap: US$87.2m

MindWalk Holdings Corp. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.

Amphastar Pharmaceuticals

Market Cap: US$1.4b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Ensysce Biosciences

Market Cap: US$6.3m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

X4 Pharmaceuticals

Market Cap: US$73.7m

A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.

Initiator Pharma

Market Cap: SEK 258.8m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

UroGen Pharma

Market Cap: US$957.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Centessa Pharmaceuticals

Market Cap: US$2.8b

A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.